Among the large number of variants belonging to the pancreatic-type secretory
ribonuclease (
RNase) superfamily, bovine
pancreatic ribonuclease (
RNase A) is the proto-type and bovine seminal
RNase (
BS-RNase) represents the unique natively dimeric member. In the present manuscript, we evaluate the anti-tumoral property of these RNases in pancreatic
adenocarcinoma cell lines and in nontumorigenic cells as normal control. We demonstrate that
BS-RNase stimulates a strong anti-proliferative and pro-apoptotic effect in
cancer cells, while
RNase A is largely ineffective. Notably, we reveal for the first time that
BS-RNase triggers Beclin1-mediated autophagic
cancer cell death, providing evidences that high proliferation rate of
cancer cells may render them more susceptible to autophagy by
BS-RNase treatment. Notably, to improve the autophagic response of
cancer cells to
BS-RNase we used two different strategies: the more basic (as compared to WT
enzyme) G38K mutant of
BS-RNase, known to interact more strongly than wt with the acidic membrane of
cancer cells, or
BS-RNase oligomerization (tetramerization or formation of larger oligomers). Both mutant
BS-RNase and
BS-RNase oligomers potentiated autophagic cell death as compared to WT native dimer of
BS-RNase, while the various
RNase A oligomers remained completely ineffective. Altogether, our results shed more light on the mechanisms lying at the basis of
BS-RNase antiproliferative effect in
cancer cells, and support its potential use to develop new anti-
cancer strategies.